Designs and develops high throughput mutagenesis technologies for studying functional genomics in mammalian systems. Lexicon went public in June 2000 (NASDAQ:LEXG).
Investors 1
| Date | Name | Website |
| - | Bay City C... | baycitycap... |
| Date | Name | Website |
| - | Bay City C... | baycitycap... |